Quotient Sciences Enhances Manufacturing Partnership for Ultra-Rare Disease Treatment Quotient Sciences has announced an extended partnership with Ipsen to manufacture a groundbreaking therapy for the ultra-rare disease Fibrodysplasia Ossificans Progressiva (FOP).

Quotient Sciences Enhances Manufacturing Partnership for Ultra-Rare Disease Treatment #United_States #Philadelphia #Ipsen #Quotient_Sciences #Fibrodysplasia

Lindus Health and Quotient Sciences Join Forces to Revolutionize Drug Development Processes Lindus Health and Quotient Sciences forge a strategic collaboration, enhancing patient recruitment and streamlining processes in clinical trials.

Lindus Health and Quotient Sciences Join Forces to Revolutionize Drug Development Processes #USA #Boston #Clinical_Trials #Lindus_Health #Quotient_Sciences

Quotient Sciences and Intrepid Labs Collaborate to Revolutionize AI in Drug Development Quotient Sciences partners with Intrepid Labs to utilize AI in enhancing drug formulation processes, aiming for improved efficiency and outcomes in early drug development.

Quotient Sciences and Intrepid Labs Collaborate to Revolutionize AI in Drug Development #United_Kingdom #Nottingham #Intrepid_Labs #Quotient_Sciences #ANDROMEDA

Quotient Sciences and CPI Collaborate on RNA Drug Development Venture Quotient Sciences and CPI have entered a joint venture to expedite RNA therapy development, integrating unique manufacturing and expertise to enhance clinical trial efficiency.

Quotient Sciences and CPI Collaborate on RNA Drug Development Venture #United_Kingdom #CPI #Nottingham #RNA_Therapy #Quotient_Sciences